Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis

Industrial Health

Volumn 50, Issue 4, 2012, Pages 299-306

  Pelclová, Daniela ^a   Fenclová, Zdenka ^a   Vlčková, Štěpánka ^a   Lebedová, Jindřiška ^a   Syslová, Kamila ^b   Pecha, Ondřej ^a   Běláček, Jaromír ^a   Navrátil, Tomáš ^c   Kuzma, Marek ^d   Kačer, Petr ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

^d Institute of Mcrobiology   (Czech Republic)

Author keywords

Asbestosis; Exhaled breath condensate; LC ESI MS MS; Leukotrienes; Lung fibrosis; Plasma; Silicosis; SPE; Urine

Indexed keywords

LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4;

AGED; ARTICLE; ASBESTOSIS; BLOOD; BREATH ANALYSIS; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; SILICOSIS; URINE;

AGED; ASBESTOSIS; BREATH TESTS; FEMALE; HUMANS; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENES; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SILICOSIS;

EID: 84864974693     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.MS1274     Document Type: Article

References (33)

1. Corradi M, Gergelova P, Mutti A (2010) Use of exhaled breath condensate to investigate occupational lung diseases. Curr Opin Allergy Clin Immunol 10, 93-98.
2. Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M (1996) Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 97, 1827-1836.
3. Tufvesson E, Bozovic G, Hesselstrand R, Bjermer L, Scheja A (2010) Wuttge DM Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients. Rheumatology 49, 2322-2326.
4. Huang SK, Peters-Golden M (2008) Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? Chest 133, 1442-1450.
5. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ (2003) Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 21, 589-93.
6. Ono E, Mita H, Taniguchi M, Higashi N, Tsuburai T, Hasegawa M, Miyazaki E, Kumamoto T, Akiyama K (2008) Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation. J Allergy Clin Immunol 122, 768-73.
7. Klusackova P, Lebedova J, Kacer P, Kuzma M, Brabec M, Pelclova D, Fenclova Z, Navratil T (2008) Leukotrienes and 8-isoprostane in exhaled breath condensate in bronchoprovocation tests with occupational allergens. Prostaglandins Leukot Essent Fatty Acids 78, 281-92.
8. Vannella KM, McMillan TR, Charbeneau RP, Wilke CA, Thomas PE, Toews GB, Peters-Golden M, Moore BB (2007) Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J Immunol 179, 7883-90.
9. James AJ, Penrose JF, Cazaly AM, Holgate ST, Sampson AP (2006) Human bronchial fibroblasts express the 5-lipoxygenase pathway. Respir Res 7, 102.
10. Voelkel NF, Tuder RM, Wade K, Hoper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F (1996) Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest 97, 2491-8.
11. Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, Moore BB (2002) Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165, 229-35.
12. Shimbori C, Shiota N, Okunishi H (2010) Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice. Exp Lung Res 36, 292-301.
13. Holgate ST, Peter-Golden M, Panettieri RA, Henderson WR (2003) Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111, S18-S34.
14. Ono E, Mita H, Taniguchi M, Higashi N, Tsuburai T, Miyazaki E, Kumamoto T, Akiyama K (2008) Comparison of cysteinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid. Clin Exp Allergy 38, 1866-1874.
15. Lehtonen H, Oksa P, Lehtimaki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Jarvenpaa R, Uitti J, Moilanen E (2007) Increased alveolar nitric oxide concentration and high levels of leukotriene B-4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 62, 602-607.
16. Pelclová D, Fenclova Z, Kacer P, Navratil T, Kuzma M, Lebedova J, Klusackova P (2007) 8-isoprostane and leukotrienes in exhaled breath condensate in Czech subjects with silicosis. Ind Health 45, 766-774.
17. Pelclova D, Fenclova Z, Kacer P, Kuzma M, Navratil T, Lebedova J, Klusackova P (2007) Arachidonic acid derivatives in the exhaled breath condensate in pneumoconioses and their correlation with individual factors. Chem Listy 101, 144-146.
18. Flamand N, Mancuso P, Serezani CHC, Brock TG (2007) Leukotrienes: mediators that have been typecast as villains. Cell Mol Life Sci 64, 2657-2670.
19. Funk CD (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 4, 664-672.
20. Klingenberg R, Hansson GK (2009) Treating infammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 30, 2838-2844.
21. Vicenová B, Vopalensky V, Burysek L, Pospisek M (2009) Emerging role of interleukin-1 in cardiovascular diseases. Physiol Res 58, 481-498.
22. Pelclova D, Navratil T, Fenclova Z, Vlckova S, Kupka K, Urban P, Ridzon P, Zikan V, Landova L, Syslova K, Kuzma M, Kacer P (2011) Increased oxidative/nitrosative stress markers measured non-invasively in patients with high 2,3,7,8-tetrachloro-dibenzo-p-dioxin plasma level. Neuroendocrinol Lett 32 (Suppl 1), 71-76.
23. Taylor GW, Black P, Turner N, Taylor I, Maltby NH, Fuller RW, Dollery CT (1989) Urinary leukotriene-e4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1, 584-588.
24. Taniguchi M, Higashi N, Ono E, Mita H, Akiyama K (2008) Hyperleukotrieneuria in patients with allergic and inflammatory disease. Allergol Int 57, 313-320.
25. ILO (2002) Guidelines for the Use for the ILO International Classification of Radiographs of Pneumoconiosis. International Labour Office, Geneva.
26. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive summary: global strategy for diagnosis, management, and prevention of COPD. http://www. goldcopd.com/. Accessed September 1, 2011.
27. Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C Wirtz H, ATS/ERS Task Force on Exhaled Breath Condensate (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26, 523-548.
28. Syslová K, Kacer P, Kuzma M, Najmanova V, Fenclova Z, Vlckova S, Lebedova J, Pelclova D (2009) Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. J Chromatogr B Analyt Technol Biomed Life Sci 877, 2477-2486.
29. Mohr C, Davis GS, Graebner C, Amann S, Hemenway DR, Gemsa D (1992) Reduced release of leukotrienes B4 and C4 from alveolar macrophages of rats with silicosis. Am J Respir Cell Mol Biol 7, 542-547.
30. Bartůňková J, Pelclova D, Fenclova Z, Sediva A, Lebedova J, Tesar V, Hladikova M, Klusackova P (2006) Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med 49, 569-576.
31. Pelclová D, Bartunkova J, Fenclova Z, Lebedova J, Hladikova M, Benakova H (2003) Asbestos exposure and antineutrophil cytoplasmic Antibody (ANCA) positivity. Arch Environ Health 58, 662-668.
32. Pelclová D, Fenclova Z, Kacer P, Kuzma M, Navratil T, Lebedova J (2008) Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. Ind Health 46, 484-489.
33. Pelclová D, Fenclova Z, Syslova K, Vlckova S, Lebedova J, Pecha O, Belacek J, Navratil T, Kuzma M, Kacer P (2011) Oxidative stress markers in exhaled breath condensate in lung fibroses are not significantly affected by systemic diseases. Ind Health 49, 746-754.